Literature DB >> 6391987

Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes.

R Taylor, D J Husband, S M Marshall, W M Tunbridge, K G Alberti.   

Abstract

Adipocyte insulin binding and insulin sensitivity to stimulation of lipogenesis were assessed in a group of extremely 'brittle' diabetic patients who were resistant to subcutaneous insulin therapy and had required frequent and prolonged hospital admission. These patients had significantly lower maximum adipocyte insulin binding (1.78 +/- 0.18%) than age-, sex- and weight-matched stable diabetic control subjects (2.57 +/- 0.36%; p less than 0.05). Scatchard analysis suggested that the decreased binding was secondary to reduced receptor affinity with no change in receptor number. Adipocytes from the brittle subjects displayed resistance to insulin stimulation of lipogenesis compared with those from diabetic or normal control groups (half-maximal stimulation at 34 +/- 4, 15 +/- 3 and 13 +/- 2 pmol/l respectively; p less than 0.01 between brittle and stable diabetic groups). In the one subject who was treated with intraperitoneal insulin, the changes in insulin binding and sensitivity were found to have reverted towards normal. The peripheral tissue abnormalities of brittle diabetes may exacerbate the clinical syndrome although the relationship of these changes to the primary cause of the syndrome is uncertain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391987     DOI: 10.1007/BF00273908

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Microdetermination of long-chain fatty acids in plasma and tissues.

Authors:  V P DOLE; H MEINERTZ
Journal:  J Biol Chem       Date:  1960-09       Impact factor: 5.157

2.  Rapid regulation of plasma membrane insulin receptors.

Authors:  V Pezzino; R Vigneri; N B Pliam; I D Goldfine
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

3.  Binding and receptor-mediated degradation of insulin in adipocytes.

Authors:  J Gliemann; O Sonne
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

4.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

5.  Decreased insulin binding to adipocytes and circulating monocytes from obese subjects.

Authors:  J M Olefsky
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

6.  Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting.

Authors:  R S Bar; P Gorden; J Roth; C R Kahn; P De Meyts
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

7.  Continuous intraperitoneal insulin infusion in the management of severely brittle diabetes--a metabolic and clinical comparison with intravenous infusion.

Authors:  D J Husband; S M Marshall; S Walford; I Hanning; P D Wright; K G Alberti
Journal:  Diabet Med       Date:  1984-07       Impact factor: 4.359

8.  Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.

Authors:  K H Jørgensen; U D Larsen
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

9.  Insulin receptor binding increased by high carbohydrate low fat diet in non-insulin-dependent diabetics.

Authors:  G M Ward; R W Simpson; H C Simpson; B A Naylor; J I Mann; R C Turner
Journal:  Eur J Clin Invest       Date:  1982-04       Impact factor: 4.686

10.  Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes.

Authors:  O Pedersen; E Hjøllund; H Beck-Nielsen; H O Lindskov; O Sonne; J Gliemann
Journal:  Diabetologia       Date:  1981-06       Impact factor: 10.122

View more
  1 in total

1.  Brittle diabetes--present concepts.

Authors:  G V Gill; S Walford; K G Alberti
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.